Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

The Peptide Craze – What You Need to Know

Managing Acute Heart Failure After Discharge: A Practical Guide for GPs

Oral Contraceptives on the PBS – A Practical Guide for GPs

The Impact of PFAS & Other Endocrine Disrupting Chemicals on Fertility

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis